How to make it in Africa: Pitfalls,Challenges,Investment opportunities and Success Stories. This presentation was given at Imperial College London and highlighted the role corporate venture capital can play in the growth of Africa's economy.
make it in Africa • Sean Ndiho Obedih • Open Innovation and Corporate Venture capital in Africa. • Video • Talent • Deal sizes/Dominant players • Exits • Success stories • Opportunities.
make it in Africa Exits: Financial services was the most active exit sector (23%), but other sectors such as food and beverage (9%) and telecommunications (8%) also made good showings, illustrating the rise of the African consumer.
make it in Africa • MPESA/VODAFONE (Kenya) • Spotted in 2002,tried in 2004 and Launched in 2007 with £1M funding from Vodafone&DFID • Now in Africa, India and Afghanistan
make it in Africa • Aspen/GSK • In 2009, GSK took a 16 per cent stake in Aspen, • granting it the right to distribute GSK products in sub-Saharan Africa. GSK also handed over a German manufacturing facility along with marketing rights to eight international products. • In 2010 Aspen took control of a GSK generic drugs unit in Australia, • In October it bought a GSK plant in France and thrombosis treatments Arixtra (fondaparinux sodium) and Fraxiparine (nadroparin) in a deal valued at $1.1bn. • Those deals and others such as an alliance with Merck & Co helped Aspen become Africa’s biggest drug maker with 6,000 employees and sales of around $1.9bn in the year ended June 30 2013, up 27 per cent year-on-year. • It now says it is the ninth-largest generic drug maker in the world. • GSK, recently sold 28.2 million shares in Aspen, netting around £425m ($741m).